*Five Years Citation in Google scholar (2016 - 2020) is. 1451*   *    IJPR IS INDEXED IN ELSEVIER EMBASE & EBSCO *       

logo

INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH

A Step Towards Excellence
Published by : Advanced Scientific Research
ISSN
0975-2366
Current Issue
Article In Press
No Data found.
ADOBE READER

(Require Adobe Acrobat Reader to open, If you don't have Adobe Acrobat Reader)

Index Page 1
Click here to Download
IJPR 9[3] July - September 2017 Special Issue

July - September 9[3] 2017

Click to download
 

Article Detail

Label
Label
Valproate-Induced Malformation In Epilepsy: Data Mining of Canadian Adverse Reaction Monitoring Program Safety Reports

Author: HARDIK BHATT, TUSHAR DESAI
Abstract: Purpose: In present investigation, we analysed process and preliminary results of combining data from Canadian Adverse Reaction Monitoring Program databases for monitoring of anti-epileptic drug safety. Objective: The objective of present investigation was to extract data related to adverse events associated with Valproate from Canadian Adverse Reaction database for possible congenital anomaly signal detection of Valproate with qualitative analysis and also to evaluate the frequency of the Valproate induced malformation within different stratified groups. Methods: A total of 4855 case reports of anti-epileptic drugs within period of January 2000 to June 2016 were downloaded from database. There were 1066 cases for Valproate and its analogue reported during this interval. These reports containing information of adverse events associated with Valproate were investigated. Statistical pharmacovigilance tools were used for quantitative signal detection of drug-related adverse reactions, which includes proportional reporting ratio, 95% confidence interval of proportional reporting ratio, the reporting odds ratio and Reporting ratio. Results: Total of 6 reports related to Valproate-induced malformation was obtained from Canadian Adverse Reaction database. For Valproate-induced malformation, the proportional reporting ratio, reporting odds ratio and reporting ratio was found to be 2.92, 2.95 & 2.15 respectively. Lower and upper limits of 95% confidence interval of proportional reporting ratio were found to be 1.047 & 8.175 respectively. Conclusion: Data mining from Canadian Adverse Reaction database was found useful for examining Valproate-induced malformation related adverse event. The data strongly suggest the necessity of risk minimization measures for the congenital anomaly associated risk with anti-epileptic drugs.
Keyword: Valproate, Signal detection, Adverse drug events, Malformation
Download: Request For Article
 




ONLINE SUBMISSION
USER LOGIN


Username
Password
Login | Register
News & Events
SCImago Journal & Country Rank

Terms and Conditions
Disclaimer
Refund Policy
Instrucations for Subscribers
Privacy Policy

Copyrights Form

0.12
2018CiteScore
 
8th percentile
Powered by  Scopus
Google Scholar

hit counters free